LAB

Standard BioTools Inc. Common Stock (LAB)

Stock · NASDAQ · Industrials

$0.6351as of 10/16/2026

Price chart

Open in TradingView

Active signals

High Beta29.6%
200 SMA Touch0.0%
Resistance level
$0.865606
Industry
Biotechnology: Laboratory Analytical Instruments

LAB Signal Track Record

How signals performed across all stocks →

What LAB's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike41-6.7%34%
Bollinger Band Breakdown25+1.7%52%
Bollinger Band Breakout23-2.9%26%
200-Day Moving Average TouchActive now21-2.9%48%
Any 20-session window (baseline)-1.9%46%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About LAB

Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments, consumables, and assays for…

Sector
Industrials
Industry
Biotechnology: Laboratory Analytical Instruments
Employees
385

Fundamentals

1-day range
$0.6301$0.6713
Market cap
$313.21M
P/E (trailing)
2.92
P/E (forward)
-65.84
EPS (trailing)
$0.22
Dividend yield
—
Beta
1.54
Avg. volume
1.45M
52-week range
$0.6251$1.72
Next earnings: November 3, 2026 · EPS estimate $-0.01confirmed

How Standard BioTools Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$85.33MSG&A$109.86M (129%)Cost of Revenue$42.79M (50%)R&D$25.99M (30%)LAB

Source: 10-K filed Mar 16, 2026 · via SEC EDGAR / Finnhub

Gross Profit$42.54M(50%)
Operating Income-$110.25M(-129%)

Forecasts

1 analyst ratings

Buy 67%
Hold 33%
Sell 0%
1-year price forecast
High
$1.35
+112.6%
Median
$1.35
+112.6%
Low
$1.35
+112.6%

Standard BioTools Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • LAB
    Standard BioTools Inc. Common Stock
    $0.63
    ▼ 4.55%
    Market cap $313.21MP/E 2.92
    $0.6251$1.72
  • PACB
    Pacific Biosciences of California Inc. Common Stock
    $1.73
    ▼ 11.73%
    Market cap $361.85MP/E —
    $1.07$3.44
  • QTRX
    Quanterix Corporation Common Stock
    $2.87
    ▼ 6.51%
    Market cap $180.42MP/E —
    $2.15$8.77
  • SEER
    Seer Inc. Class A Common Stock
    $2.03
    ▼ 0.49%
    Market cap $120.41MP/E —
    $1.55$2.41
  • NAUT
    Nautilus Biotechnology Inc. Common Stock
    $2.06
    ▼ 4.63%
    Market cap $112.76MP/E —
    $0.8399$4.31
  • RPID
    Rapid Micro Biosystems Inc. Class A Common Stock
    $0.764
    ▼ 9.59%
    Market cap $96.03MP/E —
    $0.8087$4.94
  • CTKB
    Cytek Biosciences Inc. Common Stock
    $5.25
    ▼ 2.96%
    Market cap $537.23MP/E —
    $3.31$6.21

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
1.78M
Disposed
716.7K

Institutional Ownership

March 31, 2026

Total shares held
292.54M
Total value held
$268.26M
Institutional holders
149
Top holders this quarter
  • Unknown88.78M
  • Unknown58.65M
  • Unknown26.17M
  • Unknown24.76M
  • Unknown16.02M
  • Unknown12.82M
  • Unknown7.29M
  • Unknown6.56M
  • Unknown5.65M
  • Unknown4.66M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.